CLPT
Clearpoint Neuro IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$266.55M
P/E Ratio
—
EPS
$-0.90
Beta
1.18
52W High
$30.10
52W Low
$8.60
50-Day MA
$11.84
200-Day MA
$14.16
Dividend Yield
—
Profit Margin
-69.10%
Forward P/E
12.11
PEG Ratio
0.60
About Clearpoint Neuro Inc
ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $36.97M |
| Gross Profit (TTM) | $22.69M |
| EBITDA | $-21.48M |
| Operating Margin | -50.40% |
| Return on Equity | -95.60% |
| Return on Assets | -20.40% |
| Revenue/Share (TTM) | $1.31 |
| Book Value | $0.95 |
| Price-to-Book | 9.70 |
| Price-to-Sales (TTM) | 7.21 |
| EV/Revenue | 7.68 |
| EV/EBITDA | -7.07 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 34.00% |
| Shares Outstanding | $29.66M |
| Float | $25.33M |
| % Insiders | 8.46% |
| % Institutions | 51.47% |
Historical Volatility
HV 10-Day
46.67%
HV 20-Day
71.93%
HV 30-Day
117.27%
HV 60-Day
98.85%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($25.00 target)
2
BuyData last updated: 4/10/2026